NetProphet
NetProphet maps transcription factor (TF) networks to identify direct TF targets and infer DNA-binding specificities from promoter sequences for analysis of gene regulatory mechanisms.
Key Features:
- Data Light Approach: Functions effectively with limited data inputs and does not rely on extensive datasets such as chromatin immunoprecipitation sequencing (ChIP-seq) or genome-wide chromatin marks.
- Integration of Multiple Approaches: Combines multiple gene expression–based network mapping strategies to improve predictive accuracy relative to any single method.
- Utilization of DNA Binding Domain Similarities: Incorporates similarities in TF DNA binding domains to group TFs and enhance target prediction.
- Inference from Noisy Data: Infers DNA-binding specificities from promoter sequences starting from a preliminary noisy network and uses those specificities to iteratively refine the network map.
Scientific Applications:
- Systems biology and genomics: Elucidates gene regulatory mechanisms by mapping TF-target relationships within regulatory networks.
- Non-model organisms and novel cell types: Enables TF network studies when ChIP-seq and comprehensive chromatin datasets are unavailable, facilitating analysis in less-characterized species or cell types.
Methodology:
Combines multiple gene expression–based mapping approaches, exploits DNA-binding domain similarities among TFs to predict targets, and iteratively refines network maps by inferring DNA-binding specificities from promoter sequences starting from an initial noisy network.
Topics
Details
- Tool Type:
- command-line tool
- Programming Languages:
- R, Python
- Added:
- 6/18/2018
- Last Updated:
- 11/25/2024
Operations
Publications
Kang Y, Liow H, Maier EJ, Brent MR. NetProphet 2.0: mapping transcription factor networks by exploiting scalable data resources. Bioinformatics. 2017;34(2):249-257. doi:10.1093/bioinformatics/btx563. PMID:28968736. PMCID:PMC5860202.
PMID: 28968736
PMCID: PMC5860202
Funding: - NIH: HG000045
- National Human Genome Research Institute: AI087794